MiR-193a-3p potently promotes multi-chemoresistance in both HCC [24] and BCa by repressing its three downstream targets: SRSF2, PLAU, HIC2, LOXL4, PSEN1 and HOXC9 [21-24]. Here, SRSF2 is linked to hepatocellular carcinoma.